Journal article

Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy

J Shortt, AK Hsu, RW Johnstone

Oncogene | NATURE PUBLISHING GROUP | Published : 2013

DOI: 10.1038/onc.2012.599

Citation metrics

46Web of Science
55Scopus

Keywords

Immune Modulation
Humans
Science & Technology
Chromosome Deletion
Human-Immunodeficiency-Virus
Multiple Myeloma
Life Sciences & Biomedicine
In-Vitro
Natural-Killer-Cell
Immunomodulation
Antineoplastic Agents
Oncology
Neoplasms
Diamond-Blackfan Anemia
Myelodysplastic Syndromes
Hematological Malignancies
Animals
Lenalidomide-Induced Immunomodulation
Epigenesis, Genetic
Multiple-Myeloma Cells
Commonly Deleted Region
T Regulatory Cells
Biochemistry & Molecular Biology
Cell Biology
Nf-Kappa-B
Thalidomide
Chromosomes, Human, Pair 5
Therapeutics
Necrosis-Factor-Alpha
Immunologic Factors
Genetics & Heredity